These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32464235)
1. Kidney targeted delivery of asiatic acid using a FITC labeled renal tubular-targeting peptide modified PLGA-PEG system. He J; Chen H; Zhou W; Chen M; Yao Y; Zhang Z; Tan N Int J Pharm; 2020 Jun; 584():119455. PubMed ID: 32464235 [TBL] [Abstract][Full Text] [Related]
2. Development of glutathione-conjugated asiatic acid-loaded bovine serum albumin nanoparticles for brain-targeted drug delivery. Raval N; Mistry T; Acharya N; Acharya S J Pharm Pharmacol; 2015 Nov; 67(11):1503-11. PubMed ID: 26316160 [TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles decorated with BDNF-derived peptide for neuron-targeted delivery of PTEN inhibitor. Xu J; Chau Y Eur J Pharm Sci; 2018 Nov; 124():37-45. PubMed ID: 30145338 [TBL] [Abstract][Full Text] [Related]
4. [Oral absorption of asiatic acid nanoparticles modified with PEG]. Zhang YW; Yin LN; Huang XY; Liang ZH; Chen XX; Wang SH Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2784-2788. PubMed ID: 29098838 [TBL] [Abstract][Full Text] [Related]
5. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy. Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518 [TBL] [Abstract][Full Text] [Related]
6. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer. He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149 [TBL] [Abstract][Full Text] [Related]
7. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related]
8. CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells. Luo X; Yang Y; Kong F; Zhang L; Wei K Int J Pharm; 2019 Jun; 564():340-349. PubMed ID: 31002934 [TBL] [Abstract][Full Text] [Related]
9. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
10. SP94 Peptide-Functionalized PEG-PLGA Nanoparticle Loading with Cryptotanshinone for Targeting Therapy of Hepatocellular Carcinoma. Nie X; Liu Y; Li M; Yu X; Yuan W; Huang S; Ren D; Wang Y; Wang Y AAPS PharmSciTech; 2020 Apr; 21(4):124. PubMed ID: 32342227 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma. Xin L; Zhang HT; Yang WF; Li YF; Liu C Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29229675 [TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery. Rayaprolu BM; Strom JG Drug Dev Ind Pharm; 2013 Jul; 39(7):1046-52. PubMed ID: 22758209 [TBL] [Abstract][Full Text] [Related]
13. Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake. Wang G; Li Q; Chen D; Wu B; Wu Y; Tong W; Huang P Theranostics; 2019; 9(21):6191-6208. PubMed ID: 31534545 [TBL] [Abstract][Full Text] [Related]
14. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752 [TBL] [Abstract][Full Text] [Related]
15. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue. Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349 [TBL] [Abstract][Full Text] [Related]
16. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced. Song X; Wang J; Xu Y; Shao H; Gu J Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022 [TBL] [Abstract][Full Text] [Related]
17. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells. Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479 [TBL] [Abstract][Full Text] [Related]
18. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization. Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710 [TBL] [Abstract][Full Text] [Related]